The Effects of Cervical Sensorimotor Control Challenges on Gait Patterns, Cervical Sensorimotor Control During Dynamic Tasks
Launched by NATIONAL CHENG KUNG UNIVERSITY · Aug 4, 2024
Trial Information
Current as of July 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how challenges with neck control affect walking and other movements in people with chronic neck pain (CNP). Researchers want to understand how these challenges impact overall performance and symptoms during dynamic activities, like walking. The trial is currently not recruiting participants but aims to include healthy adults without pain and patients who have had neck pain lasting for at least three months.
To be eligible for the study, participants must be between 18 and 65 years old, and people with CNP should have pain in their neck area that isn’t new and has been bothering them for a while. Those who have had serious injuries, surgeries, or certain health conditions that could affect balance or movement may not be able to join the study. Participants will likely engage in tasks that test their neck control and walking abilities, helping researchers learn more about how these factors are connected.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy asymptomatic adults will not have any complaints of current pain and impairments of neuromusculoskeletal systems within the last 6 months.
- • For patients with CNP
- • Pain was unilateral or bilateral between the superior nuchal line and 1st thoracic vertebra
- • Neck pain persisting for 3 months and above
- • Average pain intensity of last pain episode was between 2 and 8 based on the numeric rating scale (NRS).
- Exclusion criteria:
- • ◾For patients with CNP and healthy asymptomatic adults
- • Acute or the first onset of neck pain
- • Traumatic cause of pain
- • Previous fracture or surgery of the spine
- • Diagnosed cardiopulmonary diseases, for example, chronic obstructive pulmonary disease, pulmonary tuberculosis, asthma, chronic bronchitis, pulmonary emphysema
- • Diagnosed gastrointestinal and abdominal conditions which may interfere daily activities within the past 6 months
- • Medical conditions that may affect balance and study procedures (e.g. neurological diseases, vestibular disorders, malignant tumors)
- • Metabolic diseases such as anemia and diabetes
- • Smoking, plan to pregnant or in pregnancy
- • Psychological disorders (affect questionnaire responses)
- • Unable to walk independently
- • Corrected visual abnormalities or individuals unable to wear contact lenses for vision correction due to the potential interference of wearing VR head-mounted display with glasses.
About National Cheng Kung University
National Cheng Kung University (NCKU) is a prestigious research institution located in Tainan, Taiwan, renowned for its commitment to advancing medical science and innovation. With a strong emphasis on interdisciplinary collaboration, NCKU conducts cutting-edge clinical trials aimed at improving healthcare outcomes and addressing critical health challenges. The university leverages its extensive academic resources and state-of-the-art facilities to foster high-quality research and development, ensuring that its clinical trials adhere to rigorous ethical standards and regulatory compliance. NCKU's dedication to education, research, and community service positions it as a leading sponsor in the field of clinical research, contributing significantly to the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tainan, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported